(Q37656294)

21 August 2017

1 reference

title

Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art. (English)

1 reference

hypertrophic cardiomyopathy

21 August 2017

main subject

1 reference

Deborah H Kwon

1

1 reference

21 August 2017

Milind Y Desai

series ordinal

2

1 reference

21 August 2017

publication date

1 January 2010

1 reference

Expert Review of Cardiovascular Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

103-111

1 reference

Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

A contemporary approach to hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

The management of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Management of hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Sudden death due to troponin T mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Cardiovascular magnetic resonance imaging: current and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

An acquired disease component in hypertrophic cardiomyopathy: new clinical clarifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Cardiovascular magnetic resonance in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Sudden Death in Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Significance of Papillary Muscle Abnormalities Identified by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.09.108

21 January 2018

Identifiers

DOI

10.1586/ERC.09.108

1 reference

21 August 2017

1 reference